Table 1 Characteristics of pediatric patients in their initial visits
Variable | All pediatric patients | 7–12 years | 13–18 years | p valuea |
|---|---|---|---|---|
n = 121 | n = 68 | n = 53 | ||
Sex, n (%) | 0.9342 | |||
Boy | 69 (57.02) | 39 (57.35) | 30 (56.60) | |
Girl | 52 (42.98) | 29 (42.65) | 23 (43.40) | |
Type of CKD | 0.0616 | |||
CAKUT: Renal agenesis/hypoplasia | 46 (38.02) | 33 (48.53) | 13 (24.53) | |
CAKUT: others | 19 (15.70) | 9 (13.24) | 10 (18.87) | |
Glomerular disease | 27 (22.31) | 13 (19.12) | 14 (26.42) | |
Others | 29 (23.97) | 13 (19.12) | 16 (30.19) | |
eGFR at baseline, ml/min/1.73m2,group, n (%) (n = 120) | ||||
≥ 90 | 82 (67.77) | 52 (77.61) | 30 (56.60) | 0.0428 |
60–89 | 26 (21.49) | 11 (16.42) | 15 (28.30) | |
30–59 | 12 (9.92) | 4 (5.97) | 8 (15.09) | |
Comorbid conditions at baseline, n (%) | ||||
Growth retardation (n = 120) | 19 (15.83) | 9 (13.43) | 10 (18.87) | 0.4180 |
Overweight (n = 119) | 36 (30.25) | 15 (22.39) | 21 (40.38) | 0.0340 |
Hypertension (n = 118) | 45 (38.14) | 21 (31.82) | 24 (46.15) | 0.1114 |
Hyperlipidemia (n = 118) | 20 (16.95) | 11 (16.67) | 9 (17.31) | 0.9266 |
Mineral bone disorders/Anemia (n = 120) | 16 (13.33) | 3 (4.48) | 13 (24.53) | 0.0013 |
Hyperuricemia (n = 120) | 28 (23.33) | 8 (11.94) | 20 (37.74) | 0.0009 |
Proteinuria (n = 119) | 44 (36.97) | 19 (28.36) | 25 (48.08) | 0.0271 |
Number of comorbid conditions, n (%) (n = 118) | 0.0011 | |||
None | 25 (21.19) | 19 (28.79) | 6 (11.54) | |
1 | 29 (24.58) | 19 (28.79) | 10 (19.23) | |
2 | 36 (30.51) | 21 (31.82) | 15 (28.85) | |
≥ 3 | 28 (23.73) | 7 (10.61) | 21 (40.38) | |